NCT04385355

Brief Summary

The objective of this study is to evaluate the radiographic changes on the marginal peri-implant bone level on bone level implants with a narrower transmucosal abutment, in comparison to the conventional abutment, both of 3mm height

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 12, 2020

Completed
4.4 years until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

September 29, 2021

Status Verified

September 1, 2021

Enrollment Period

1 month

First QC Date

May 6, 2020

Last Update Submit

September 28, 2021

Conditions

Keywords

periimplant bone lossabutment designtransmucosal abutment

Outcome Measures

Primary Outcomes (1)

  • Radiographic marginal periimplant bone level changes

    Measured as the distance from the bone crest to the first implant-to-bone contact. This will be assessed on parallelized periapical radiographies

    from baseline (connection of the definitive abutment) to 6 and 12 months after the definitive prostheses will be connected, and finally 3 years later

Secondary Outcomes (6)

  • Probing pocket depth

    6 and 12 months after the definitive prostheses will be connected, and finally 3 years later

  • Papilla refill

    6 and 12 months after the definitive prostheses will be connected, and finally 3 years later

  • Bleeding on probing

    6 and 12 months after the definitive prostheses will be connected, and finally 3 years later

  • Plaque index

    6 and 12 months after the definitive prostheses will be connected, and finally 3 years later

  • Patient Reported Outcomes Measurements

    6 and 12 months after the definitive prostheses will be connected, and finally 3 years later

  • +1 more secondary outcomes

Study Arms (2)

Control Group

OTHER

Control group will receive an intermediate transmucosal abutment with conventional diameter and 3mm height, once the implants are placed.

Device: Conventional transmucosal abutment design

Test Group

EXPERIMENTAL

Test group will receive an intermediate transmucosal abutment with a TCP design, narrower than the conventional one, of 3mm height, once the implants are placed

Device: Narrow transmucosal abutment design

Interventions

The macroscopic design of the intermediate transmucosal abutment will be evaluated on terms of the marginal peri-implant bone levels using two identical devices, if only being the test device narrower than the control one

Control Group

The macroscopic design of the intermediate transmucosal abutment will be evaluated on terms of the marginal peri-implant bone levels using two identical devices, if only being the test device narrower than the control one

Test Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Absence of systemic and periodontal pathology, over 18 years of age, with a plaque index below 25%.
  • Absence of at least one tooth, with natural adjacent teeth, allowing a prosthetic rehabilitation with an osseointegrated implant and a prosthetic unit.
  • Adequate bone quality available, allowing placement of MOZO GRAU® implants InHex STD QUATTRO with diameters of 3.75 mm or 4.25 mm and lengths of 8, 10 and 11.5 mm.
  • Natural teeth or implants with fixed restoration as antagonists.

You may not qualify if:

  • Systemic factors:
  • Continuous administration of systemic medication that can interfere with the bone metabolism or medical conditions requiring prolonged use of steroids and / or medications that can interfere with bone metabolism.
  • History of leukocyte dysfunction and deficiency, immunodeficiency syndromes, kidney failure or bone metabolic disorders, such as osteoporosis.
  • Physical disability that may interfere with proper oral hygiene.
  • Use of any investigational medication or device within the previous 30 days to implant surgery in the study.
  • Alcoholism or drug addiction
  • Smoker of more than 10 cigarettes per day.
  • Conditions or circumstances that could prevent compliance with participation in study or interfere with the analysis of results, such as a history of breach or unreliability.
  • Local factors:
  • History of local radiotherapy.
  • Bruxism.
  • Diseases that affect the oral mucosa, such as oral lichen planus.
  • Untreated periodontitis.
  • Persistent intraoral infection.
  • Post-extraction alveoli not cured (less than 6 weeks after extraction).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Santiago de Compostela

Santiago de Compostela, La Coruña, 15782, Spain

RECRUITING

Related Publications (7)

  • Alves CC, Munoz F, Cantalapiedra A, Ramos I, Neves M, Blanco J. Marginal bone and soft tissue behavior following platform switching abutment connection/disconnection--a dog model study. Clin Oral Implants Res. 2015 Sep;26(9):983-91. doi: 10.1111/clr.12385. Epub 2014 Apr 16.

    PMID: 24735458BACKGROUND
  • Berglundh T, Lindhe J. Dimension of the periimplant mucosa. Biological width revisited. J Clin Periodontol. 1996 Oct;23(10):971-3. doi: 10.1111/j.1600-051x.1996.tb00520.x.

    PMID: 8915028BACKGROUND
  • Blanco J, Pico A, Caneiro L, Novoa L, Batalla P, Martin-Lancharro P. Effect of abutment height on interproximal implant bone level in the early healing: A randomized clinical trial. Clin Oral Implants Res. 2018 Jan;29(1):108-117. doi: 10.1111/clr.13108. Epub 2017 Dec 8.

    PMID: 29222809BACKGROUND
  • Ericsson I, Persson LG, Berglundh T, Marinello CP, Lindhe J, Klinge B. Different types of inflammatory reactions in peri-implant soft tissues. J Clin Periodontol. 1995 Mar;22(3):255-61. doi: 10.1111/j.1600-051x.1995.tb00143.x.

    PMID: 7790533BACKGROUND
  • Koutouzis T, Adeinat B, Ali A. The influence of abutment macro-design on clinical and radiographic peri-implant tissue changes for guided, placed, and restored implants: A 1-year randomized controlled trial. Clin Oral Implants Res. 2019 Sep;30(9):882-891. doi: 10.1111/clr.13493. Epub 2019 Jun 24.

    PMID: 31180160BACKGROUND
  • Novoa L, Batalla P, Caneiro L, Pico A, Linares A, Blanco J. Influence of Abutment Height on Maintenance of Peri-implant Crestal Bone at Bone-Level Implants: A 3-Year Follow-up Study. Int J Periodontics Restorative Dent. 2017 Sep/Oct;37(5):721-727. doi: 10.11607/prd.2762.

    PMID: 28817138BACKGROUND
  • Souza AB, Alshihri A, Kammerer PW, Araujo MG, Gallucci GO. Histological and micro-CT analysis of peri-implant soft and hard tissue healing on implants with different healing abutments configurations. Clin Oral Implants Res. 2018 Oct;29(10):1007-1015. doi: 10.1111/clr.13367. Epub 2018 Sep 23.

    PMID: 30246409BACKGROUND

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
None of the participants or the outcomes assessor will know the device (transmucosal abutment) received. The care provider will connect the transmucosal abutment while the surgery, after opening the randomization envelope; and the investigator will identify the participant's group while analysing the radiographs.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: For each participant on the test group will be another participant on the control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 6, 2020

First Posted

May 12, 2020

Study Start

October 1, 2024

Primary Completion

October 31, 2024

Study Completion

November 1, 2024

Last Updated

September 29, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations